Gen Wealth Partners Inc Bristol Myers Squibb CO Transaction History
Gen Wealth Partners Inc
- $229 Billion
- Q3 2024
A detailed history of Gen Wealth Partners Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gen Wealth Partners Inc holds 2,261 shares of BMY stock, worth $130,414. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,261
Previous 2,161
4.63%
Holding current value
$130,414
Previous $89.7 Million
32.67%
% of portfolio
0.05%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,536Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.9 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.15 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.36 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.5 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.52 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $123B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...